1. Home
  2. PRME vs ICHR Comparison

PRME vs ICHR Comparison

Compare PRME & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.74

Market Cap

601.1M

Sector

Health Care

ML Signal

HOLD

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$17.61

Market Cap

555.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRME
ICHR
Founded
2019
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
601.1M
555.0M
IPO Year
2022
2016

Fundamental Metrics

Financial Performance
Metric
PRME
ICHR
Price
$3.74
$17.61
Analyst Decision
Buy
Buy
Analyst Count
6
5
Target Price
$9.31
$26.50
AVG Volume (30 Days)
4.1M
769.5K
Earning Date
11-07-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,977,000.00
$957,337,000.00
Revenue This Year
$179.58
$13.65
Revenue Next Year
N/A
$5.40
P/E Ratio
N/A
N/A
Revenue Growth
647.13
16.86
52 Week Low
$1.11
$13.12
52 Week High
$6.94
$35.56

Technical Indicators

Market Signals
Indicator
PRME
ICHR
Relative Strength Index (RSI) 46.43 53.15
Support Level $3.26 $16.27
Resistance Level $4.08 $17.70
Average True Range (ATR) 0.32 0.79
MACD 0.07 0.43
Stochastic Oscillator 60.98 90.25

Price Performance

Historical Comparison
PRME
ICHR

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

About ICHR Ichor Holdings

Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.

Share on Social Networks: